EUVIMEDEUVIMED entdecken
Crossref

An Integrative Strategy Enhancing Nanobody Thermostability via CDR Grafting, In Silico Mutagenesis Screening, and Multiplex Evaluation

Weijie Ou iD, Jing Dan iD, Xuzhen Guo, Qiong Liu iD, Lei Tan iD

ACS Synthetic Biology · 18.07.2025 · 14 (7) · 2690-2702

DOI: 10.1021/acssynbio.5c00112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 04.07.2025. Verfasst von Weijie Ou und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, Guangdong 518055, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Complementarity Determining Regions, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shenzhen Municipal Fundamental Research Program, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesComplementarity Determining RegionsSpike Glycoprotein, CoronavirusMolecular Dynamics SimulationSARS-CoV-2MutagenesisProtein StabilityHumansProtein Engineering

Stichwörter der Autor:innen

CDR graftingComputational−experimental approachIn-silico screeningMolecular dynamics simulationNanobody thermostabilityProtein engineering

Substanzen

Single-Domain AntibodiesComplementarity Determining RegionsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, Guangdong 518055, China.
  • Medical Laboratory Department, Hejiang People's Hospital, Luzhou, Sichuan 646200, China.
  • Center for Synthetic Biology and Evolution, Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China.
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
  • Innovation Center of Suzhou, Nanjing Medical University, Suzhou, Jiangsu 215000, China.
  • National Center of Technology Innovation for Biopharmaceuticals, Suzhou, Jiangsu 215000, China.

ORCID-Profile: Weijie Ou, Jing Dan, Qiong Liu, Lei Tan

Förderung

  • National Key Research and Development Program of China
  • Shenzhen Municipal Fundamental Research Program
  • Chinese Academy of Sciences
  • Shenzhen-Hong Kong Institute of Brain Science
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University

Zitieren

APA

Ou, W., Dan, J., Guo, X., Liu, Q., & Tan, L. (2025). An Integrative Strategy Enhancing Nanobody Thermostability via CDR Grafting, In Silico Mutagenesis Screening, and Multiplex Evaluation. ACS Synthetic Biology, 14(7), 2690-2702. https://doi.org/10.1021/acssynbio.5c00112

Vancouver

Ou W, Dan J, Guo X, Liu Q, Tan L. An Integrative Strategy Enhancing Nanobody Thermostability via CDR Grafting, In Silico Mutagenesis Screening, and Multiplex Evaluation. ACS Synthetic Biology. 2025;14(7):2690-2702. doi:10.1021/acssynbio.5c00112

BibTeX
@article{Ou2025,
  author = {Ou, Weijie and Dan, Jing and Guo, Xuzhen and Liu, Qiong and Tan, Lei},
  title = {An Integrative Strategy Enhancing Nanobody Thermostability via CDR Grafting, In Silico Mutagenesis Screening, and Multiplex Evaluation},
  journal = {ACS Synthetic Biology},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {2690--2702},
  doi = {10.1021/acssynbio.5c00112}
}
Kostenlos starten →